Findus Group
Founded Year
1906Stage
Acq - Fin | AliveValuation
$0000About Findus Group
The Findus Group is a European frozen food and seafood company. The Findus Group brings together a large frozen food business in the Nordics, a large frozen and chilled seafood company in the UK and a fast growing frozen food business in France.
Missing: Findus Group's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Findus Group's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Latest Findus Group News
Feb 23, 2023
02/09 02/23/2023 | 07:41am EST Message : Completes 6th consecutive year of record annual reported revenue, Adjusted EBITDA and Adjusted EPS 2023 Adjusted EPS guidance range of €1.50 to €1.55 FELTHAM, England, Feb. 23, 2023 /PRNewswire/ -- Nomad Foods Limited (NYSE: NOMD) (the "Company" or "Nomad Foods"), today reported financial results for the three and twelve-month periods ended December 31, 2022. Key operating highlights and financial performance for the fourth quarter 2022, when compared to the fourth quarter 2021, include: Reported revenue increased 6.6% to €750 million Organic revenue increase of 7.7% Reported Profit for the period of €37 million Adjusted EBITDA up slightly to €113 million Adjusted EPS of €0.33 Key operating highlights and financial performance for the full year 2022, when compared to the full year 2021, include: Reported revenue increased 12.8% to €2,940 million Organic revenue increase of 1.8% Reported Profit for the period of €250 million Adjusted EBITDA increased 8% to €524 million Adjusted EPS of €1.68 Management Comments Stéfan Descheemaeker, Nomad Foods' Chief Executive Officer, stated, "We are pleased to report that 2022 was another year of record revenue, Adjusted EBITDA and Adjusted EPS for Nomad Foods, again proving the resilience of our operating model in a challenging macro environment. Our organic sales returned to growth, we expanded Adjusted EBITDA and Adjusted EPS by 8%, and we extended our debt maturities at competitive rates. Most importantly, we adjusted our business model in response to extraordinary changes in the market, especially in raw material sourcing and portfolio pricing. Looking ahead to 2023, the frozen food category remains great value for consumers, and we have exciting plans in place to deliver strong operational results to build value for our shareholders." Noam Gottesman, Nomad Foods' Co-Chairman and Founder, commented, "Our 2022 results mark another record financial performance for Nomad Foods. We delivered Adjusted EPS at the top-end of our guidance range, grew organic sales against a challenging consumer backdrop, finished the successful integration of Fortenova's frozen food business, and opportunistically accessed the capital markets to extend our debt maturities until mid-2028 and 2029. We enter 2023 with sales momentum, strong underlying cash generation, and financial flexibility providing the opportunity to prudently deploy capital to create value for shareholders. In addition to our ability to return capital to shareholders, we believe we have the right operational and financial plans in place to drive sustainable growth to compound value into the future." Fourth Quarter of 2022 results compared to the Fourth Quarter of 2021 Revenue increased 6.6% to €750 million. Organic revenue increase of 7.7% was driven by a 8.1% decline in volume/mix and a 15.8% increase in price. Adjusted gross profit increased 3% to €193 million. Adjusted Gross margin decreased 80 basis points to 25.7% driven by higher raw material costs driven by inflation, partially offset by higher pricing. Adjusted operating expenses increased 9% to €103 million, primarily reflecting a number of one-off costs in the quarter including a €4.5 million Cost of Living payment support package for our employees. Adjusted EBITDA up slightly to €113 million and Adjusted Profit after tax decreased 1% to €58 million due to the aforementioned factors. Adjusted EPS remained unchanged at €0.33. Reported EPS increased 31% to €0.21. Year Ended 2022 results compared to the Year Ended 2021 Revenue increased 12.8% to €2,940 million. Organic revenue increase of 1.8% was driven by a 5.9% decline in volume/mix and a 7.7% increase in price. Adjusted gross profit increased 8% to €815 million. Adjusted Gross margin decreased 120 basis points to 27.7% driven by higher raw material costs driven by inflation, partially offset by higher pricing and the inclusion of the acquisition. Adjusted operating expenses increased 12% to €380 million driven primarily by the first-time inclusion of our Adriatic region acquisition. Adjusted EBITDA increased 8% to €524 million and Adjusted Profit after tax increased 6% to €293 million, due to the aforementioned factors. Adjusted EPS increased 8% to €1.68 and Reported EPS increased 40% to €1.43. 2023 Guidance For the full year 2023, management expects Adjusted EPS of €1.50 to €1.55. Full year guidance assumes mid-single-digit revenue growth and cash flow conversion in the range of 90% to 95%. Conference Call and Webcast The Company will host a conference call with members of the executive management team to discuss these results today, Thursday, February 23, 2023 at 1:30 p.m. GMT (8:30 a.m. Eastern Standard Time). To participate on the live call, listeners in North America may dial +1-877-451-6152 and international listeners may dial +1-201-389-0879. Additionally, there will be a presentation to accompany the conference call and the call is being webcast. Both can be accessed at the Nomad Foods website at www.nomadfoods.com under Investor Relations. A replay of the conference call will be available on the Company website for two weeks following the event and can be accessed by listeners in North America by dialing +1-844-512-2921 and by international listeners by dialing +1-412-317-6671; the replay pin number is 13735336. Nomad Foods Contacts About Nomad Foods Nomad Foods (NYSE: NOMD) is Europe's leading frozen food company. The Company's portfolio of iconic brands, which includes Birds Eye, Findus, iglo, Ledo and Frikom, have been a part of consumers' meals for generations, standing for great tasting food that is convenient, high quality and nutritious. Nomad Foods is headquartered in the United Kingdom. Additional information may be found at www.nomadfoods.com . Financial Information Nomad Foods is presenting Adjusted and Organic financial information, which is considered non-IFRS financial information, for the three and twelve months ended December 31, 2022 and for comparative purposes, the three and twelve months ended December 31, 2021. Adjusted financial information for the three and twelve months ended December 31, 2022 and 2021 presented in this press release reflects the historical reported financial statements of Nomad Foods, adjusted primarily for share based payment expenses and related employer payroll taxes, non-operating M&A related costs, acquisition purchase price adjustments, exceptional items and foreign currency exchange charges/gains. Adjusted EBITDA is profit or loss for the period before taxation, net financing costs, depreciation and amortization, adjusted to exclude, when they occur, the impacts of exited markets, acquisition purchase price adjustments and exceptional items such as restructuring charges, goodwill and intangible asset impairment charges and other unusual or non-recurring items. In addition, we exclude other adjustments such as the impact of share based payment expenses and related employer payroll taxes, and non-operating M&A related costs, because we do not believe they are indicative of our normal operating costs, can vary significantly in amount and frequency, and are unrelated to our underlying operating performance. The Company believes Adjusted EBITDA provides important comparability of underlying operating results, allowing investors and management to assess operating performance on a consistent basis. Adjusted EBITDA should not be considered as an alternative to profit/(loss) for the period, determined in accordance with IFRS, as an indicator of the Company's operating performance. Adjusted Profit for the period is defined as profit for the period excluding, when they occur, the impacts of exited markets, acquisition purchase price adjustments and exceptional items such as restructuring charges, goodwill and intangible asset impairment charges, unissued preferred share dividends, as well as certain other items considered unusual or non-recurring in nature. In addition, we exclude other adjustments such as the impact of share based payment expenses and related employer payroll taxes, and non-operating M&A related costs, because we do not believe they are indicative of our normal operating costs, can vary significantly in amount and frequency, and are unrelated to our underlying operating performance. The Company believes Adjusted Profit after tax provides important comparability of underlying operating results, allowing investors and management to assess operating performance on a consistent basis. Adjusted EPS is defined as basic earnings per share excluding, when they occur, the impacts of exited markets, acquisition purchase price adjustments and exceptional items such as restructuring charges, goodwill and intangible asset impairment charges, as well as certain other items considered unusual or non-recurring in nature. In addition, we exclude other adjustments such as the impact of share based payment expenses and related employer payroll taxes, and non-operating M&A related costs, because we do not believe they are indicative of our normal operating costs, can vary significantly in amount and frequency, and are unrelated to our underlying operating performance. The Company believes Adjusted EPS provides important comparability of underlying operating results, allowing investors and management to assess operating performance on a consistent basis. Organic revenue growth/(decline) is an adjusted measurement of our operating results. The comparison for the three and twelve months ended December 31, 2022 and 2021 presented in this press release takes into consideration only those activities that were in effect during both time periods. Organic revenue growth/(decline) reflects reported revenue adjusted for currency translation and non-comparable trading items such as expansion, acquisitions, disposals, closures, trading day impacts or any other event that artificially impacts the comparability of our results period over period. Adjusted Gross Profit and adjusted gross margin exclude acquisition purchase price adjustments within cost of goods sold. Adjustments for currency translation are calculated by translating data of the current and comparative periods using a budget foreign exchange rate that is set once a year as part of the Company's internal annual forecast process. Adjusted and Organic non-IFRS financial information should be read in conjunction with the unaudited financial statements of Nomad Foods included in this press release as well as the historical financial statements of the Company previously filed with the SEC. Nomad Foods believe its non-IFRS financial measures provide an important additional measure with which to monitor and evaluate the Company's ongoing financial results, as well as to reflect its acquisitions. Nomad Foods' calculation of these financial measures may be different from the calculations used by other companies and comparability may therefore be limited. The Adjusted and Organic financial information presented herein is based upon certain assumptions that Nomad Foods believes to be reasonable and is presented for informational purposes only and is not necessarily indicative of any anticipated financial position or future results of operations that the Company will experience. You should not consider the Company's non-IFRS financial measures an alternative or substitute for the Company's reported results and are cautioned not to place undue reliance on these results and information as they may not be representative of our actual or future results as a Company. Please see on pages 8 to 16, the non-IFRS reconciliation tables attached hereto and the schedules accompanying this release for an explanation and reconciliation of the Adjusted and Organic financial information to the most directly comparable IFRS measure. The Company is unable to reconcile, without unreasonable efforts, Adjusted EPS guidance to the most directly comparable IFRS measure. (g) Expenses associated with a three-year factory optimization program, initiated in 2018, to develop a new suite of standard manufacturing and supply chain processes, that will provide a single network of optimized factories. Due to delays in delivering the program, it was extended for an additional year and completed in 2022. (h) Income and expenses associated with the settlement of tax and other liabilities relating to periods prior to acquisition by the Company. (i) Represents the elimination of share based payment charge including employer payroll taxes of €1.2 million and elimination of a non-operating M&A related credit of €0.1 million. (j) Adjusted EBITDA margin of 15.1% for the three months ended December 31, 2022 is calculated by dividing Adjusted EBITDA by Revenue of €750.2 million. (g) Expenses associated with a three-year factory optimization program, initiated in 2018, to develop a new suite of standard manufacturing and supply chain processes, that will provide a single network of optimized factories. Due to delays in delivering the program, it was extended for an additional year and completed in 2022. (h) Income and expenses associated with the settlement of contingent tax receivables, tax liabilities and other liabilities relating to periods prior to acquisition by the Company. (i) Charge for the release of shares held in escrow as part of the consideration on the acquisition of the Findus Group. (j) Represents the elimination of share based payment charge including employer payroll taxes of €8.6 million and elimination of non-operating M&A related costs of €3.1 million. (k) Adjusted EBITDA margin of 17.8% for the twelve months ended December 31, 2022 is calculated by dividing Adjusted EBITDA by Revenue of €2,939.7 million. (g) Expenses associated with a three-year factory optimization program to develop a new suite of standard manufacturing and supply chain processes, that will provide a single network of optimized factories. The project was initiated in 2018. (h) Income and expenses associated with tax and other liabilities relating to periods prior to acquisition by the Company. (i) Charge for the release of shares held in escrow as part of the consideration on the acquisition of the Findus Group. (j) Represents the elimination of share based payment charge including employer payroll taxes of €5.8 million and elimination of non-operating M&A related costs of €12.9 million. (k) Adjusted EBITDA margin of 18.7% for the twelve months ended December 31, 2021 is calculated by dividing Adjusted EBITDA by Revenue of €2,606.6 million. Forward-Looking Statements and Disclaimers Certain statements in this announcement are forward-looking statements which are based on the Company's expectations, intentions and projections regarding its future performance, anticipated events or trends and other matters that are not historical facts, including the Company's expectations regarding (i) its future operating and financial performance, including its reiterated guidance with respect to Adjusted EPS, Adjusted EPS growth for 2023; and; (ii) its ability to successfully capitalize on opportunities and maximize value for its shareholders. These statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and other factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements, including: (i) the Company's ability to effectively mitigate factors that negatively impact its supply of raw materials, including the conflict in Ukraine; (ii) the Company's ability to successfully mitigate inflationary changes in the market; (iii) the Company's ability to successfully identify suitable acquisition targets and adequately evaluate the potential performance of such acquisition targets; (iv) the Company's ability to successfully implement its strategies (including its M&A strategy) and strategic initiatives and to recognize the anticipated benefits of such strategic initiatives; (v) the Company's ability to accurately predict the performance of its Green Cuisine brand and the Findus Switzerland and Fortenova's frozen food businesses' and their impact on the Company's growth; (vi) the Company's ability to effectively compete in its markets, including the ability of Green Cuisine to effectively compete in Continental Europe; (vii) changes in consumer preferences, such as meat substitutes, and the Company's failure to anticipate and respond to such changes or to successfully develop and renovate products; (viii) the effects of reputational damage from unsafe or poor quality food products; (ix) the risk that securities markets will react negatively to actions by the Company; (x) the adequacy of the Company's cash resources to achieve its anticipated growth agenda; (xi) increases in operating costs, including labor costs, and the Company's ability to manage its cost structure; (xii) fluctuations in the availability of food ingredients and packaging materials that the Company uses in its products; (xiii) the Company's ability to protect its brand names and trademarks; (xiv) new regulations governing the import and export of goods between the UK and the European Union as a result of Brexit, as well as the potential adverse impact of Brexit on currency exchange rates, global economic conditions and cross-border agreements that affect the Company's business; (xv) loss of the Company's financial arrangements with respect to receivables factoring; (xvi) the loss of any of the Company's major customers or a decrease in demand for its products; (xvii) economic conditions that may affect the Company's future performance including exchange rate fluctuations; (xviii) the Company's ability to successfully interpret and respond to key industry trends and to realize the expected benefits of its responsive actions; (xix) the Company's failure to comply with, and liabilities related to, environmental, health and safety laws and regulations; (xx) changes in applicable laws or regulations; and (xxi) the other risks and uncertainties disclosed in the Company's public filings and any other public disclosures by the Company. Given these risks and uncertainties, prospective investors are cautioned not to place undue reliance on forward-looking statements. Forward-looking statements speak only as of the date of such statements and, except as required by applicable law, the Company does not undertake any obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise. No Offer or Solicitation This release and referenced conference call is provided for informational purposes only and does not constitute an offer to sell, or an invitation to subscribe for, purchase or exchange, any securities or the solicitation of any vote or approval in any jurisdiction, nor shall there be any sale, issuance, exchange or transfer of the securities referred to in this press release in any jurisdiction in contravention of applicable law. The release, publication or distribution of this announcement in certain jurisdictions may be restricted by law and therefore persons in such jurisdictions into which this announcement is released, published or distributed should inform themselves about and observe such restrictions.
Findus Group Frequently Asked Questions (FAQ)
When was Findus Group founded?
Findus Group was founded in 1906.
Where is Findus Group's headquarters?
Findus Group's headquarters is located at 77 Kingsway, London.
What is Findus Group's latest funding round?
Findus Group's latest funding round is Acq - Fin.
Who are the investors of Findus Group?
Investors of Findus Group include Lion Capital.
Who are Findus Group's competitors?
Competitors of Findus Group include ClaraLab and 4 more.
Compare Findus Group to Competitors
Nowaco distributes a variety of raw materials and semi-manufactured food products such as meat and seafood to the food services industry. It was founded in 1972 and is based in Aalborg, Denmark
Luiten Food is a wholesaler of food. It imports and distributes beef, mutton, lamb, game, poultry, and seafood. It serves food service, food processing, wholesale, catering, retail, and specialty stores. It was founded in 1938 and is based in Leidschendam, Netherlands.
Insight Foods Limited is establishing itself as a product innovator within the North American Seafood Industry. Built on the philosophy of quality, diligent product research and development, professional attention to detail, and buttressed by a business model that is lean and flexible, the Company has propelled itself over the $1 million dollar sales mark in just two years. With no debt, a track record with a major customer in the QSR (quick service restaurant) sector; initial Food Service launch underway in Quebec/ Ontario; and several products at the commercialization stage, Insight offered a opportunity for members of The First Angels Network
EG is an information technology (IT) company that supplies IT solutions and consultancy services for the Scandinavian market. It delivers vertical software that helps our customers move their businesses further. It offers software tools and applications for construction, utility, health care, retail, and more. The company was founded in 1977 and is based in Herning, Denmark.
Dinnissen provides pre-engineering solutions. The company offers services including in-house development and manufacturing, product intake, transport and handling, feeding, weighing, mixing and processing, milling, sifting, and packaging, among others. It was founded in 1948 and is based in Sevenum, Netherlands.
Eurofins is a researcher and provider in food, environment, pharmaceutical products testing, agro science, genomics, discovery pharmacology, and central laboratory services. It is based in Vejen, Denmark.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.